Company Filing History:
Years Active: 2016
Title: Jens Bredel Nielsen: Innovator in Metabolically Engineered Cells
Introduction
Jens Bredel Nielsen is a prominent inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of valuable compounds through metabolic engineering. His innovative work has led to the development of a patented process that utilizes recombinant micro-organisms for the synthesis of resveratrol and its derivatives.
Latest Patents
Nielsen holds a patent for "Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof." This patent describes a recombinant micro-organism that produces resveratrol via a specific biochemical pathway. The process involves several key enzymes, including phenylalanine ammonia lyase (PAL), cinnamate 4-hydroxylase (C4H), 4-coumarate-CoA ligase (4CL), and resveratrol synthase (VST). The micro-organism can be a yeast, fungus, or bacterium, showcasing the versatility of his invention.
Career Highlights
Nielsen's career is marked by his dedication to advancing biotechnological methods for producing natural compounds. His work has not only contributed to scientific knowledge but also has practical applications in various industries, including pharmaceuticals and nutraceuticals. He is associated with Evolva SA, a company focused on sustainable production of ingredients through biotechnology.
Collaborations
Throughout his career, Jens Bredel Nielsen has collaborated with notable colleagues, including Michael Katz and Hans Peter Smits. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in metabolic engineering.
Conclusion
Jens Bredel Nielsen's contributions to the field of biotechnology through his patented processes exemplify the potential of metabolic engineering in producing valuable compounds. His work continues to inspire advancements in sustainable production methods.